308 related articles for article (PubMed ID: 23242702)
1. Attacking the HIV reservoir from the immune and viral perspective.
Massanella M; Martinez-Picado J; Blanco J
Curr HIV/AIDS Rep; 2013 Mar; 10(1):33-41. PubMed ID: 23242702
[TBL] [Abstract][Full Text] [Related]
2. The challenge of viral reservoirs in HIV-1 infection.
Blankson JN; Persaud D; Siliciano RF
Annu Rev Med; 2002; 53():557-93. PubMed ID: 11818490
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus (HIV) latency: the major hurdle in HIV eradication.
Tyagi M; Bukrinsky M
Mol Med; 2012 Sep; 18(1):1096-108. PubMed ID: 22692576
[TBL] [Abstract][Full Text] [Related]
4. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
Pierson T; McArthur J; Siliciano RF
Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
[TBL] [Abstract][Full Text] [Related]
5. 1st International Workshop on HIV Persistence during Therapy. St. Martin, December 10-12, 2003.
Tossing G
Eur J Med Res; 2004 Feb; 9(2):83-6. PubMed ID: 15090294
[TBL] [Abstract][Full Text] [Related]
6. Increased T cell trafficking as adjunct therapy for HIV-1.
Fryer HR; Wolinsky SM; McLean AR
PLoS Comput Biol; 2018 Mar; 14(3):e1006028. PubMed ID: 29499057
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 Latency and Viral Reservoirs: Existing Reversal Approaches and Potential Technologies, Targets, and Pathways Involved in HIV Latency Studies.
Khanal S; Schank M; El Gazzar M; Moorman JP; Yao ZQ
Cells; 2021 Feb; 10(2):. PubMed ID: 33672138
[TBL] [Abstract][Full Text] [Related]
8. Establishment of a Novel Humanized Mouse Model To Investigate
Flerin NC; Bardhi A; Zheng JH; Korom M; Folkvord J; Kovacs C; Benko E; Truong R; Mota T; Connick E; Jones RB; Lynch RM; Goldstein H
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626677
[TBL] [Abstract][Full Text] [Related]
9. HIV reservoirs and strategies for eradication.
Smith MZ; Wightman F; Lewin SR
Curr HIV/AIDS Rep; 2012 Mar; 9(1):5-15. PubMed ID: 22249405
[TBL] [Abstract][Full Text] [Related]
10. Barriers for HIV Cure: The Latent Reservoir.
Castro-Gonzalez S; Colomer-Lluch M; Serra-Moreno R
AIDS Res Hum Retroviruses; 2018 Sep; 34(9):739-759. PubMed ID: 30056745
[TBL] [Abstract][Full Text] [Related]
11. Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3.
Sarracino A; Gharu L; Kula A; Pasternak AO; Avettand-Fenoel V; Rouzioux C; Bardina M; De Wit S; Benkirane M; Berkhout B; Van Lint C; Marcello A
mBio; 2018 Nov; 9(6):. PubMed ID: 30425153
[TBL] [Abstract][Full Text] [Related]
12. Stochastic population switch may explain the latent reservoir stability and intermittent viral blips in HIV patients on suppressive therapy.
Wang S; Rong L
J Theor Biol; 2014 Nov; 360():137-148. PubMed ID: 25016044
[TBL] [Abstract][Full Text] [Related]
13. Modeling HIV-1 Latency Using Primary CD4
Takata H; Kessing C; Sy A; Lima N; Sciumbata J; Mori L; Jones RB; Chomont N; Michael NL; Valente S; Trautmann L
J Virol; 2019 Jun; 93(11):. PubMed ID: 30918072
[TBL] [Abstract][Full Text] [Related]
14. A unified concept of HIV latency.
Bagasra O
Expert Opin Biol Ther; 2006 Nov; 6(11):1135-49. PubMed ID: 17049012
[TBL] [Abstract][Full Text] [Related]
15. Eradicating HIV-1 infection: seeking to clear a persistent pathogen.
Archin NM; Sung JM; Garrido C; Soriano-Sarabia N; Margolis DM
Nat Rev Microbiol; 2014 Nov; 12(11):750-64. PubMed ID: 25402363
[TBL] [Abstract][Full Text] [Related]
16. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation.
Chomont N; El-Far M; Ancuta P; Trautmann L; Procopio FA; Yassine-Diab B; Boucher G; Boulassel MR; Ghattas G; Brenchley JM; Schacker TW; Hill BJ; Douek DC; Routy JP; Haddad EK; Sékaly RP
Nat Med; 2009 Aug; 15(8):893-900. PubMed ID: 19543283
[TBL] [Abstract][Full Text] [Related]
17. Enhanced culture assay for detection and quantitation of latently infected, resting CD4+ T-cells carrying replication-competent virus in HIV-1-infected individuals.
Siliciano JD; Siliciano RF
Methods Mol Biol; 2005; 304():3-15. PubMed ID: 16061962
[TBL] [Abstract][Full Text] [Related]
18. Reservoirs of HIV-1 in vivo: implications for antiretroviral therapy.
Saksena NK; Potter SJ
AIDS Rev; 2003; 5(1):3-18. PubMed ID: 12875103
[TBL] [Abstract][Full Text] [Related]
19. Antibody-Mediated CD4 Depletion Induces Homeostatic CD4
Kumar NA; McBrien JB; Carnathan DG; Mavigner M; Mattingly C; White ER; Viviano F; Bosinger SE; Chahroudi A; Silvestri G; Paiardini M; Vanderford TH
J Virol; 2018 Nov; 92(22):. PubMed ID: 30185596
[TBL] [Abstract][Full Text] [Related]
20. Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs.
Coiras M; López-Huertas MR; Pérez-Olmeda M; Alcamí J
Nat Rev Microbiol; 2009 Nov; 7(11):798-812. PubMed ID: 19834480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]